Groups | S100A9 | P-value | |||
---|---|---|---|---|---|
3 + (n) | 2 + (n) | 1 + (n) | -(n) | ||
Tissue | |||||
Normal tissue (n = 40) | 0 | 0 | 8 | 32 | 0.000 |
Osteosarcoma tissue (n = 120) | 6 | 73 | 35 | 6 | |
Gender | |||||
Male (n = 71) | 4 | 46 | 17 | 4 | 0.210 |
Female (n = 49) | 2 | 27 | 18 | 2 | |
Age | |||||
> 25 (n = 47) | 1 | 28 | 16 | 2 | 0.378 |
< 25 (n = 73) | 5 | 45 | 19 | 4 | |
Site | |||||
Femur (n = 73) | 4 | 46 | 20 | 3 | 0.086 |
Tibiofibula (n = 23) | 2 | 15 | 5 | 1 | |
Other sites (n = 24) | 0 | 12 | 10 | 2 | |
Clinical stage | |||||
IA (n = 25) | 0 | 6 | 15 | 4 | 0.000 |
IB (n = 16) | 1 | 8 | 5 | 2 | |
IIA (n = 38) | 2 | 30 | 6 | 0 | |
IIB (n = 32) | 1 | 24 | 7 | 0 | |
III (n = 9) | 2 | 5 | 2 | 0 |